Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q13510
UPID:
ASAH1_HUMAN
Alternative names:
Acylsphingosine deacylase; N-acylethanolamine hydrolase ASAH1; N-acylsphingosine amidohydrolase; Putative 32 kDa heart protein
Alternative UPACC:
Q13510; E9PDS0; Q6W898; Q96AS2
Background:
Acid ceramidase, known by alternative names such as Acylsphingosine deacylase and N-acylsphingosine amidohydrolase, plays a pivotal role in the metabolism of sphingolipids. It hydrolyzes ceramides into sphingosine and free fatty acids, crucial for cell signaling pathways that regulate proliferation, apoptosis, and differentiation. This enzyme exhibits higher efficiency towards C12-ceramides and is involved in the synthesis of ceramides from fatty acids and sphingosine.
Therapeutic significance:
Acid ceramidase is linked to Farber lipogranulomatosis, a lysosomal storage disorder, and spinal muscular atrophy with progressive myoclonic epilepsy, highlighting its therapeutic potential. Targeting this protein could lead to novel treatments for these debilitating diseases.